HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Miguel A Barbancho Selected Research
Miguel A Barbancho Research Topics
Disease
3
Type 2 Diabetes Mellitus (MODY)
01/2022 - 05/2019
3
Cognitive Dysfunction
11/2019 - 08/2014
2
Aphasia (Dysphasia)
06/2015 - 05/2009
1
Heart Failure
01/2022
1
Dyspnea (Shortness of Breath)
01/2022
1
Hyperglycemia
04/2021
1
Postoperative Cognitive Complications
11/2019
1
Critical Illness (Critically Ill)
05/2019
1
Stroke (Strokes)
06/2015
1
Diabetes Mellitus
03/2015
1
Obesity
03/2015
1
Coronary Artery Disease (Coronary Atherosclerosis)
08/2014
Drug/Important Bio-Agent (IBA)
3
Insulin (Novolin)
FDA Link
01/2022 - 05/2019
2
Blood Glucose (Blood Sugar)
IBA
04/2021 - 05/2019
2
Linagliptin
IBA
04/2021 - 05/2019
2
Memantine (Namenda)
FDA Link
06/2015 - 05/2009
1
pro-brain natriuretic peptide (1-76)
IBA
01/2022
1
empagliflozin
IBA
01/2022
1
Sodium-Glucose Transporter 2 Inhibitors
IBA
01/2022
1
Diuretics
IBA
01/2022
1
Sodium-Glucose Transport Proteins
IBA
01/2022
1
Hypoglycemic Agents (Hypoglycemics)
IBA
04/2021
1
hemoglobin P (Hb P)
IBA
03/2015
1
Hemoglobins (Hemoglobin)
IBA
08/2014
1
Pharmaceutical Preparations
IBA
05/2009
Therapy/Procedure
4
Therapeutics
04/2021 - 05/2009
2
Injections
04/2021 - 05/2019
1
Length of Stay
01/2022
1
Coronary Artery Bypass (Coronary Artery Bypass Surgery)
11/2019
1
Perioperative Care
11/2019
1
Off-Pump Coronary Artery Bypass (Coronary Artery Bypass, Off Pump)
03/2015